Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Grange syndrome due to homozygous YY1AP1 missense rare variants.
|
31633303 |
2019 |
Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Biallelic YY1AP1 mutations are known to cause Grange syndrome.
|
31270375 |
2019 |
Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Loss-of-function variants in YY1AP1 have only recently been associated with Grange syndrome.
|
30556293 |
2019 |
Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly
|
0.740 |
GermlineCausalMutation
|
disease |
ORPHANET |
Exome-sequencing analysis of DNA from three affected siblings with Grange syndrome identified compound heterozygous nonsense variants in YY1AP1, and homozygous nonsense or frameshift YY1AP1 variants were subsequently identified in additional unrelated probands with Grange syndrome.
|
27939641 |
2017 |
Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Exome-sequencing analysis of DNA from three affected siblings with Grange syndrome identified compound heterozygous nonsense variants in YY1AP1, and homozygous nonsense or frameshift YY1AP1 variants were subsequently identified in additional unrelated probands with Grange syndrome.
|
27939641 |
2017 |
Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly
|
0.740 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly
|
0.740 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly
|
0.740 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hypertension, Renovascular
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Hemorrhagic stroke and renovascular hypertension with Grange syndrome arising from a novel pathogenic variant in YY1AP1.
|
31270375 |
2019 |
Hypertension, Renovascular
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Aortic Valve Insufficiency
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Borderline intellectual disability
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Carotid Stenosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Patent ductus arteriosus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ventricular Septal Defects
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Hypertensive disease
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Renal Artery Stenosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Stricture of artery
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Syndactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Brachydactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Clinodactyly of fingers
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Weight decreased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased susceptibility to fractures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Short palm
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|